NEWS AND EVENTS

Latest News

November 15, 2021

Penrose TherapeuTx Appoints Pharmaceutical Leader David Sherris, Ph.D., as President and Chief Executive Officer

Read more

May 11, 2021

Former FDA and NIH Leader Dr. Vicki Seyfert-Margolis Joins Penrose TherapeuTx Scientific Advisory Board

Read more

April 6, 2021

Penrose TherapeuTx Expands Scientific Advisory Board with Three World-Renowned Oncology Researchers

Read more

March 10, 2021

Prominent Mitochondrial Researcher Dr. Navdeep Chandel Joins Penrose TherapeuTx Scientific Advisory Board

Read more

February 11, 2021

Penrose TherapeuTx Appoints Oncology Clinical Development Veteran Bhardwaj Desai, M.D. as Chief Development Officer
Read more

Featured Articles

November 30, 2021

dbusiness

David Sherris Named President and CEO of Penrose TherapeuTx

Read more

May 28, 2021

MATTER

Penrose TherapeuTx Closes $15.3 Million in Private Funding to Advance Novel Mitochondria Modifying Agent Platform

Read more

March 30, 2021

dbusiness

Penrose TherapeuTx Names Navdeep Chandel to Scientific Advisory Board

Read more

February 5, 2021

dbusiness

Penrose TherapeuTx Announces Mark de Souza as CEO

Read more

December 7, 2020

Crain’s Chicago Business

Cannabis CEO joins cancer startup
Read more

December 7, 2020

BioSpace

BioSpace Movers & Shakers
Read more

Penrose TherapeuTx

Corporate Headquarters
245 First Street, Suite 1800
Cambridge, MA 02142

R&D Facilities
46701 Commerce Center Dr
Plymouth, MI 48170
USA

2020 © ALL RIGHTS RESERVED Penrose TherapeuTx

Penrose TherapeuTx is a subsidiary of Tribar Healthcare Partners, Inc.

Terms of Use | Privacy Policy |  Copyright Policy